dibenzylchlorethamine has been researched along with Cancer of Mouth in 1 studies
Dibenzylchlorethamine: An alpha adrenergic antagonist.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weisburger, EK | 1 |
| Ward, JM | 1 |
| Brown, CA | 1 |
1 other study available for dibenzylchlorethamine and Cancer of Mouth
| Article | Year |
|---|---|
Dibenamine: selective protection against diethylnitrosamine-induced hepatic carcinogenesis but not oral, pharyngeal and esophageal carcinogenesis.
Topics: Animals; Body Weight; Dibenzylchlorethamine; Esophageal Neoplasms; Liver; Liver Neoplasms; Male; Mou | 1974 |